Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease

Gianluca Iacobellis, C. R. Di Gioia, M. Di Vito, L. Petramala, D. Cotesta, V. De Santis, D. Vitale, L. Tritapepe, C. Letizia

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

The aim of the study was to test 1) whether chronic and stable coronary artery disease (CAD) could downregulate epicardial fat adrenomedullin synthesis and secretion, and decrease intracoronary plasma adrenomedullin levels, and 2) whether intracoronary plasma adrenomedullin levels could be related to epicardial adipose tissue adrenomedullin gene and protein expression in subjects with CAD. We examined 12 patients with CAD who required coronary artery bypass graft (CABG) and 10 patients with non-CAD who underwent cardiac surgery for valve replacement. Plasma levels of adrenomedullin were measured in peripheral vein circulation, in left coronary artery (LCA) and coronary sinus (CS) during coronary angiography. Epicardial adipose tissue biopsy for Reverse Transcription and Real-Time PCR (RT-PCR) adrenomedullin mRNA analysis and Western Blotting (WB) protein expression was performed during cardiac surgery in all subjects. Peripheral, LCA, and CS plasma adrenomedullin levels were significantly lower in CAD patients than in those with non-CAD (3.0±0.9 vs. 4.4±0.9pg/ml p<0.01; 2.9±1 vs. 4.05±0.8pg/ml, p<0.01, 3.1±0.9 vs. 3.98±0.9pg/ml p=0.04, respectively). However, CS adrenomedullin levels were not statistically different than those in LCA suggesting that adrenomedullin was not secreted from epicardial fat into the coronary artery lumen. Epicardial fat adrenomedullin mRNA levels and protein expression were lower in patients with CAD than in those with non-CAD (p<0.01 for both). We conclude that 1) epicardial fat adrenomedullin gene and protein expression can be downregulated in CAD subjects, and 2) intracoronary adrenomedullin levels are lower in CAD. No evidence that epicardial adipose tissue really contributes intracoronary adrenomedullin can be provided at this time.

Original languageEnglish
Pages (from-to)855-860
Number of pages6
JournalHormone and Metabolic Research
Volume41
Issue number12
DOIs
StatePublished - Dec 17 2009
Externally publishedYes

Fingerprint

Adrenomedullin
Adipose Tissue
Coronary Artery Disease
Tissue
Coronary Sinus
Coronary Vessels
Fats
Plasmas
Arteries
Surgery
Thoracic Surgery
Proteins
Down-Regulation
Gene Expression
Messenger RNA
Angiography
Biopsy
Heart Valves
Transcription
Coronary Angiography

Keywords

  • Adrenomedullin
  • Coronary artery disease
  • Epicardial adipose tissue
  • Epicardial fat

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical
  • Endocrinology, Diabetes and Metabolism

Cite this

Iacobellis, G., Di Gioia, C. R., Di Vito, M., Petramala, L., Cotesta, D., De Santis, V., ... Letizia, C. (2009). Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease. Hormone and Metabolic Research, 41(12), 855-860. https://doi.org/10.1055/s-0029-1231081

Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease. / Iacobellis, Gianluca; Di Gioia, C. R.; Di Vito, M.; Petramala, L.; Cotesta, D.; De Santis, V.; Vitale, D.; Tritapepe, L.; Letizia, C.

In: Hormone and Metabolic Research, Vol. 41, No. 12, 17.12.2009, p. 855-860.

Research output: Contribution to journalArticle

Iacobellis, G, Di Gioia, CR, Di Vito, M, Petramala, L, Cotesta, D, De Santis, V, Vitale, D, Tritapepe, L & Letizia, C 2009, 'Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease', Hormone and Metabolic Research, vol. 41, no. 12, pp. 855-860. https://doi.org/10.1055/s-0029-1231081
Iacobellis, Gianluca ; Di Gioia, C. R. ; Di Vito, M. ; Petramala, L. ; Cotesta, D. ; De Santis, V. ; Vitale, D. ; Tritapepe, L. ; Letizia, C. / Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease. In: Hormone and Metabolic Research. 2009 ; Vol. 41, No. 12. pp. 855-860.
@article{c9f6f25c213540beafbc1541ca69c9cc,
title = "Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease",
abstract = "The aim of the study was to test 1) whether chronic and stable coronary artery disease (CAD) could downregulate epicardial fat adrenomedullin synthesis and secretion, and decrease intracoronary plasma adrenomedullin levels, and 2) whether intracoronary plasma adrenomedullin levels could be related to epicardial adipose tissue adrenomedullin gene and protein expression in subjects with CAD. We examined 12 patients with CAD who required coronary artery bypass graft (CABG) and 10 patients with non-CAD who underwent cardiac surgery for valve replacement. Plasma levels of adrenomedullin were measured in peripheral vein circulation, in left coronary artery (LCA) and coronary sinus (CS) during coronary angiography. Epicardial adipose tissue biopsy for Reverse Transcription and Real-Time PCR (RT-PCR) adrenomedullin mRNA analysis and Western Blotting (WB) protein expression was performed during cardiac surgery in all subjects. Peripheral, LCA, and CS plasma adrenomedullin levels were significantly lower in CAD patients than in those with non-CAD (3.0±0.9 vs. 4.4±0.9pg/ml p<0.01; 2.9±1 vs. 4.05±0.8pg/ml, p<0.01, 3.1±0.9 vs. 3.98±0.9pg/ml p=0.04, respectively). However, CS adrenomedullin levels were not statistically different than those in LCA suggesting that adrenomedullin was not secreted from epicardial fat into the coronary artery lumen. Epicardial fat adrenomedullin mRNA levels and protein expression were lower in patients with CAD than in those with non-CAD (p<0.01 for both). We conclude that 1) epicardial fat adrenomedullin gene and protein expression can be downregulated in CAD subjects, and 2) intracoronary adrenomedullin levels are lower in CAD. No evidence that epicardial adipose tissue really contributes intracoronary adrenomedullin can be provided at this time.",
keywords = "Adrenomedullin, Coronary artery disease, Epicardial adipose tissue, Epicardial fat",
author = "Gianluca Iacobellis and {Di Gioia}, {C. R.} and {Di Vito}, M. and L. Petramala and D. Cotesta and {De Santis}, V. and D. Vitale and L. Tritapepe and C. Letizia",
year = "2009",
month = "12",
day = "17",
doi = "10.1055/s-0029-1231081",
language = "English",
volume = "41",
pages = "855--860",
journal = "Hormone and Metabolic Research",
issn = "0018-5043",
publisher = "Georg Thieme Verlag",
number = "12",

}

TY - JOUR

T1 - Epicardial adipose tissue and intracoronary adrenomedullin levels in coronary artery disease

AU - Iacobellis, Gianluca

AU - Di Gioia, C. R.

AU - Di Vito, M.

AU - Petramala, L.

AU - Cotesta, D.

AU - De Santis, V.

AU - Vitale, D.

AU - Tritapepe, L.

AU - Letizia, C.

PY - 2009/12/17

Y1 - 2009/12/17

N2 - The aim of the study was to test 1) whether chronic and stable coronary artery disease (CAD) could downregulate epicardial fat adrenomedullin synthesis and secretion, and decrease intracoronary plasma adrenomedullin levels, and 2) whether intracoronary plasma adrenomedullin levels could be related to epicardial adipose tissue adrenomedullin gene and protein expression in subjects with CAD. We examined 12 patients with CAD who required coronary artery bypass graft (CABG) and 10 patients with non-CAD who underwent cardiac surgery for valve replacement. Plasma levels of adrenomedullin were measured in peripheral vein circulation, in left coronary artery (LCA) and coronary sinus (CS) during coronary angiography. Epicardial adipose tissue biopsy for Reverse Transcription and Real-Time PCR (RT-PCR) adrenomedullin mRNA analysis and Western Blotting (WB) protein expression was performed during cardiac surgery in all subjects. Peripheral, LCA, and CS plasma adrenomedullin levels were significantly lower in CAD patients than in those with non-CAD (3.0±0.9 vs. 4.4±0.9pg/ml p<0.01; 2.9±1 vs. 4.05±0.8pg/ml, p<0.01, 3.1±0.9 vs. 3.98±0.9pg/ml p=0.04, respectively). However, CS adrenomedullin levels were not statistically different than those in LCA suggesting that adrenomedullin was not secreted from epicardial fat into the coronary artery lumen. Epicardial fat adrenomedullin mRNA levels and protein expression were lower in patients with CAD than in those with non-CAD (p<0.01 for both). We conclude that 1) epicardial fat adrenomedullin gene and protein expression can be downregulated in CAD subjects, and 2) intracoronary adrenomedullin levels are lower in CAD. No evidence that epicardial adipose tissue really contributes intracoronary adrenomedullin can be provided at this time.

AB - The aim of the study was to test 1) whether chronic and stable coronary artery disease (CAD) could downregulate epicardial fat adrenomedullin synthesis and secretion, and decrease intracoronary plasma adrenomedullin levels, and 2) whether intracoronary plasma adrenomedullin levels could be related to epicardial adipose tissue adrenomedullin gene and protein expression in subjects with CAD. We examined 12 patients with CAD who required coronary artery bypass graft (CABG) and 10 patients with non-CAD who underwent cardiac surgery for valve replacement. Plasma levels of adrenomedullin were measured in peripheral vein circulation, in left coronary artery (LCA) and coronary sinus (CS) during coronary angiography. Epicardial adipose tissue biopsy for Reverse Transcription and Real-Time PCR (RT-PCR) adrenomedullin mRNA analysis and Western Blotting (WB) protein expression was performed during cardiac surgery in all subjects. Peripheral, LCA, and CS plasma adrenomedullin levels were significantly lower in CAD patients than in those with non-CAD (3.0±0.9 vs. 4.4±0.9pg/ml p<0.01; 2.9±1 vs. 4.05±0.8pg/ml, p<0.01, 3.1±0.9 vs. 3.98±0.9pg/ml p=0.04, respectively). However, CS adrenomedullin levels were not statistically different than those in LCA suggesting that adrenomedullin was not secreted from epicardial fat into the coronary artery lumen. Epicardial fat adrenomedullin mRNA levels and protein expression were lower in patients with CAD than in those with non-CAD (p<0.01 for both). We conclude that 1) epicardial fat adrenomedullin gene and protein expression can be downregulated in CAD subjects, and 2) intracoronary adrenomedullin levels are lower in CAD. No evidence that epicardial adipose tissue really contributes intracoronary adrenomedullin can be provided at this time.

KW - Adrenomedullin

KW - Coronary artery disease

KW - Epicardial adipose tissue

KW - Epicardial fat

UR - http://www.scopus.com/inward/record.url?scp=71849093597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71849093597&partnerID=8YFLogxK

U2 - 10.1055/s-0029-1231081

DO - 10.1055/s-0029-1231081

M3 - Article

C2 - 19623513

AN - SCOPUS:71849093597

VL - 41

SP - 855

EP - 860

JO - Hormone and Metabolic Research

JF - Hormone and Metabolic Research

SN - 0018-5043

IS - 12

ER -